CanSino Biologics, Inc. Class H (HK:6185) has released an update.
CanSino Biologics Inc. has announced the composition of its board of directors, which includes Dr. Xuefeng YU as Chairman and Executive Director, alongside other executive, non-executive, and independent directors. The company also disclosed the structure of its three Board committees—Audit, Remuneration and Assessment, and Nomination—with details on each member’s committee roles.
For further insights into HK:6185 stock, check out TipRanks’ Stock Analysis page.
